Will Amylyx’s ALS Drug Benefit From US FDA’s Aduhelm Experience?

 
• By Derrick Gingery
  
Astrocyte and blood vessel
The second advisory committee meeting will offer another opportunity for the public to learn about FDA's thinking on AMX0035. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers